tradmap

COCH Envoy Medical, Inc.

$6.69 +3.08%

Data as of close

Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Envoy Medical, Inc. (COCH) is a healthcare company in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, with a market capitalization of $52 million. Shares last traded at $6.69, 29.6% below their 52-week high. Over the past year the stock is down 14.2%. Revenue grew 7.1% year over year.

Market Cap
$52M
Shares Out
7.7M
EPS (TTM)
-$7.70
P/E (TTM)*
—
P/S Ratio
249.48
P/B Ratio
15.64
Dividend / Share
—
Dividend Yield
—
52-Week High
$9.50
52-Week Low
$3.82
Volume (venue)
1,336
Avg Vol (3m, venue)
277.232

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+13.62%
1M
+1.35%
3M
-4.43%
6M
-2.86%
YTD
+1.19%
1Y
-14.23%

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. COCH split history →

Technicals

RSI (14)
53.08
SMA (50)
$6.85
SMA (200)
$6.87
Price vs SMA50
-2.30%
Price vs SMA200
-2.64%
ATR (14)
$0.32

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$207000
Net Income
-$23M
Gross Margin
-385.5%
Operating Margin
—
Net Margin
—
Return on Equity
-708.5%
Return on Assets
-97.7%
Current Ratio
1.73
Debt / Equity
6.13
Revenue Growth (YoY)
+7.1%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

COCH Dividend History

Per-share growth (1y CAGR)
-39.9%
Fiscal year endTotal dividends paidPer share*Payout ratio
2025-12-31 $2M $0.08 —
2024-12-31 $2M $0.13 —

*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.

Compare payers on the highest-dividend-yield screener.

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.70 2026-08-10
Q1 2026 -$0.80 2026-05-11
Q4 2025 (derived) -$2.70 2026-03-23
FY 2025 -$12.30 2026-03-23
Q3 2025 -$3.50 2025-11-10
Q2 2025 -$3.20 2025-07-31

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Orthopedic, Prosthetic & Surgical Appliances & Supplies peers

COCH vs 14 industry peers (Orthopedic, Prosthetic & Surgical Appliances & Supplies), by market cap. Data as of close

P/S vs peers
249.48 / 2.67 med
+9245% premium
1–14 of 14
ISRGIntuitive Surgical$151.5B51.2313.0825.5%+1.13%
EWEdwards Lifesciences$53.7B53.498.2515.4%+1.35%
STESteris$22.7B28.253.7713.3%+2.70%
ZBHZimmer Biomet$18.6B23.012.189.5%+2.98%
ALGNAlign Technology$11.0B26.482.6510.0%+2.86%
MSAMsa Safety Inc$7.2B22.983.7116.1%+4.76%
ESTAEstablishment Labs Holdings Inc.$1.8B—7.40-15.8%-2.14%
CDRECadre Holdings, Inc.$1.4B37.461.975.3%+4.02%
ENOVEnovis Corp$1.2B—0.52-48.0%+3.51%
AVRAnteris Technologies Global Corp.$562M—250.82—-8.63%
SMTISanara MedTech Inc.$296M—2.69-29.2%-1.98%
INGNInogen Inc$182M—0.60-8.1%+0.00%
LAKELAKELAND INDUSTRIES INC$89M—0.47-14.0%+1.24%
NTRBNutriBand Inc.$77M———+1.04%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.